Non-Steroidal Joint Injections Gaining in Popularity

Non-Steroidal Joint Injections Gaining in Popularity

A survey found most veterinarians who specialize in horses and primarily deal with lameness issues use non-steroidal intra-articular joint therapies in their patients.

A survey found most veterinarians who specialize in horses and primarily deal with lameness issues use non-steroidal intra-articular joint therapies in their patients.
Posté par Christa Lesté-Lasserre, MA | 26 mai 2021 |
When treating joint pain with injections, practitioners generally reach for the corticosteroids first. But more veterinarians are choosing to treat with non-steroidal intra-articular therapies (NSIATs). That’s particularly the case for those who specialize in horses and primarily deal with lameness issues, according to results from a new survey.
Autologous conditioned plasma (also known as platelet-rich plasma, PRP), autologous conditioned serum (ACS), autologous protein solution (APS), cellular products like stem, stromal, and progenitor cell therapy, and polyacrylamide hydrogel are relatively new injectable joint therapies for horses. Scientists still don’t fully understand their use and benefits in the horse, but the fact that increasingly more practitioners are offering them suggests people find them helpful. It also means researchers will be able to collect more information regarding their use in clinical cases, said Lindsey Boone, DVM, PhD, Dipl. ACVS, an assistant professor of equine surgery and sports medicine at Auburn University’s College of Veterinary Medicine, in Alabama.
“These products have a place in the treatment of joint injury, and the more we use them the more we will learn, for the benefit of our equine athletes and partners,” she said.

Click to read the full article  NonSteroidal Joint Injections Gaining in Popularity

 

 

 
 

Précédent